[go: up one dir, main page]

GB0919889D0 - Drug composition and its use in therapy - Google Patents

Drug composition and its use in therapy

Info

Publication number
GB0919889D0
GB0919889D0 GBGB0919889.6A GB0919889A GB0919889D0 GB 0919889 D0 GB0919889 D0 GB 0919889D0 GB 0919889 A GB0919889 A GB 0919889A GB 0919889 D0 GB0919889 D0 GB 0919889D0
Authority
GB
United Kingdom
Prior art keywords
therapy
drug composition
drug
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0919889.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocopea Ltd
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41509324&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB0919889(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to GBGB0919889.6A priority Critical patent/GB0919889D0/en
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of GB0919889D0 publication Critical patent/GB0919889D0/en
Priority to CN2010800516299A priority patent/CN102753174A/en
Priority to JP2012538415A priority patent/JP2013510841A/en
Priority to PH1/2012/501369A priority patent/PH12012501369A1/en
Priority to CA2780703A priority patent/CA2780703A1/en
Priority to NZ599949A priority patent/NZ599949A/en
Priority to RU2012124038/15A priority patent/RU2519086C2/en
Priority to PCT/GB2010/051895 priority patent/WO2011058373A2/en
Priority to MX2012005532A priority patent/MX2012005532A/en
Priority to BR112012011227A priority patent/BR112012011227A2/en
Priority to EP10825831A priority patent/EP2498777A2/en
Priority to AU2010317667A priority patent/AU2010317667B2/en
Priority to PE2012000649A priority patent/PE20130147A1/en
Priority to UAA201207164A priority patent/UA108993C2/en
Priority to US13/446,217 priority patent/US20120252824A1/en
Priority to CO12078027A priority patent/CO6551744A2/en
Priority to IL219768A priority patent/IL219768A0/en
Priority to ZA2012/04248A priority patent/ZA201204248B/en
Priority to US14/287,017 priority patent/US10016437B2/en
Priority to US14/287,014 priority patent/US9314465B2/en
Priority to US14/287,015 priority patent/US9308211B2/en
Priority to US14/488,215 priority patent/US20150005325A1/en
Priority to US14/687,393 priority patent/US20150216869A1/en
Priority to JP2016001487A priority patent/JP6118919B2/en
Priority to US14/991,892 priority patent/US20160120899A1/en
Priority to US15/061,656 priority patent/US9700561B2/en
Priority to US15/063,465 priority patent/US9675618B2/en
Priority to US15/144,800 priority patent/US20160271197A1/en
Priority to US15/144,798 priority patent/US20160271136A1/en
Priority to US16/042,670 priority patent/US10420812B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0919889.6A 2009-06-16 2009-11-13 Drug composition and its use in therapy Ceased GB0919889D0 (en)

Priority Applications (30)

Application Number Priority Date Filing Date Title
GBGB0919889.6A GB0919889D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy
AU2010317667A AU2010317667B2 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy
PE2012000649A PE20130147A1 (en) 2009-11-13 2010-11-12 PHARMACEUTICAL COMBINATION OF THEOBROMINE AND A NON-OPIOID ANTITUSSIVE AGENT
NZ599949A NZ599949A (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy
MX2012005532A MX2012005532A (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy.
PH1/2012/501369A PH12012501369A1 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy
CA2780703A CA2780703A1 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy
CN2010800516299A CN102753174A (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy
RU2012124038/15A RU2519086C2 (en) 2009-11-13 2010-11-12 Medical combination with theobromine and using it in treatment
PCT/GB2010/051895 WO2011058373A2 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy
JP2012538415A JP2013510841A (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy
BR112012011227A BR112012011227A2 (en) 2009-11-13 2010-11-12 theobromine and agent combined with another non-opioid antitussive and its therapeutic use
EP10825831A EP2498777A2 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy
UAA201207164A UA108993C2 (en) 2009-11-13 2010-12-11 MEDICINAL COMBINATION WITH THEOBROMINE AND ITS APPLICATION IN Cough
US13/446,217 US20120252824A1 (en) 2009-06-16 2012-04-13 Drug Combinations and Uses in Treating a Coughing Condition
CO12078027A CO6551744A2 (en) 2009-11-13 2012-05-11 COMBINATION OF DRUGS WITH THEOBROMINE AND ITS USE IN THERAPY
IL219768A IL219768A0 (en) 2009-11-13 2012-05-13 Drug combination with thebromine and its use in therapy
ZA2012/04248A ZA201204248B (en) 2009-11-13 2012-06-11 Drug combination with theobromine and its use in therapy
US14/287,015 US9308211B2 (en) 2009-06-16 2014-05-24 Drug combinations and uses in treating a coughing condition
US14/287,017 US10016437B2 (en) 2009-06-16 2014-05-24 Drug combinations and uses in treating a coughing condition
US14/287,014 US9314465B2 (en) 2009-06-16 2014-05-24 Drug combinations and uses in treating a coughing condition
US14/488,215 US20150005325A1 (en) 2009-06-16 2014-09-16 Drug Combinations and Uses in Treating a Coughing Condition
US14/687,393 US20150216869A1 (en) 2009-06-16 2015-04-15 Drug Combinations and Uses in Treating a Coughing Condition
JP2016001487A JP6118919B2 (en) 2009-11-13 2016-01-07 Drug combination with theobromine and its use in therapy
US14/991,892 US20160120899A1 (en) 2009-06-16 2016-01-08 Drug Combinations and Uses in Treating a Coughing Condition
US15/061,656 US9700561B2 (en) 2009-06-16 2016-03-04 Drug combinations and uses in treating a coughing condition
US15/063,465 US9675618B2 (en) 2009-06-16 2016-03-07 Drug combinations and uses in treating a coughing condition
US15/144,800 US20160271197A1 (en) 2009-06-16 2016-05-02 Drug Combinations and Uses in Treating a Coughing Condition
US15/144,798 US20160271136A1 (en) 2009-06-16 2016-05-02 Drug Combinations and Uses in Treating a Coughing Condition
US16/042,670 US10420812B2 (en) 2009-06-16 2018-07-23 Drug combinations and uses in treating a coughing condition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0919889.6A GB0919889D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy

Publications (1)

Publication Number Publication Date
GB0919889D0 true GB0919889D0 (en) 2009-12-30

Family

ID=41509324

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0919889.6A Ceased GB0919889D0 (en) 2009-06-16 2009-11-13 Drug composition and its use in therapy

Country Status (17)

Country Link
EP (1) EP2498777A2 (en)
JP (2) JP2013510841A (en)
CN (1) CN102753174A (en)
AU (1) AU2010317667B2 (en)
BR (1) BR112012011227A2 (en)
CA (1) CA2780703A1 (en)
CO (1) CO6551744A2 (en)
GB (1) GB0919889D0 (en)
IL (1) IL219768A0 (en)
MX (1) MX2012005532A (en)
NZ (1) NZ599949A (en)
PE (1) PE20130147A1 (en)
PH (1) PH12012501369A1 (en)
RU (1) RU2519086C2 (en)
UA (1) UA108993C2 (en)
WO (1) WO2011058373A2 (en)
ZA (1) ZA201204248B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US20190008850A1 (en) * 2015-12-30 2019-01-10 Paul J. Markovitz Method of treating schizophrenia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834479A (en) * 1993-03-05 1998-11-10 Mayer; David J. Method and composition for alleviating pain
SK69799A3 (en) * 1996-11-25 2000-06-12 Procter & Gamble Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
HUP9700654A2 (en) * 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
US20030206942A1 (en) * 1998-09-25 2003-11-06 Neema Kulkarni Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
US6207674B1 (en) * 1999-12-22 2001-03-27 Richard A. Smith Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants
JP4343953B2 (en) * 2003-05-29 2009-10-14 ユニリーバー・ナームローゼ・ベンノートシヤープ Hair treatment composition
US20060153926A1 (en) * 2005-01-10 2006-07-13 Bascom Charles C Compositions, products and methods for controlling weight in a mammal
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
US20080176955A1 (en) * 2007-01-16 2008-07-24 Victory Pharma, Inc. Combined administration of benzonatate and guaifenesin

Also Published As

Publication number Publication date
CN102753174A (en) 2012-10-24
CO6551744A2 (en) 2012-10-31
JP2013510841A (en) 2013-03-28
EP2498777A2 (en) 2012-09-19
AU2010317667A1 (en) 2012-06-07
RU2012124038A (en) 2013-12-20
NZ599949A (en) 2013-08-30
PH12012501369A1 (en) 2012-10-22
IL219768A0 (en) 2012-07-31
ZA201204248B (en) 2013-02-27
AU2010317667B2 (en) 2014-05-29
BR112012011227A2 (en) 2017-06-13
WO2011058373A2 (en) 2011-05-19
JP6118919B2 (en) 2017-04-19
WO2011058373A3 (en) 2011-07-07
CA2780703A1 (en) 2011-05-19
UA108993C2 (en) 2015-07-10
MX2012005532A (en) 2012-09-28
RU2519086C2 (en) 2014-06-10
JP2016128439A (en) 2016-07-14
PE20130147A1 (en) 2013-03-13

Similar Documents

Publication Publication Date Title
ZA201206062B (en) Aminotetraline derivatives,pharmaceutical compositions containing them,and their use in therapy
IL218169A (en) Quinazoline compounds and pharmaceutical compositions comprising same for use in therapy
GB0817207D0 (en) therapeutic apsac compounds and their use
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
IL214244A0 (en) Scriptaid isosteres and their use in therapy
GB0921803D0 (en) Drug composition and its use in therapy
HK1168283A1 (en) Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto sorcs1
IL219768A0 (en) Drug combination with thebromine and its use in therapy
GB2460178B (en) Depsipeptides and their therapeutic use
IL219769A0 (en) Drug combination with theromine and its use in therapy
GB2460181B (en) Depsipeptides and their therapeutic use
GB0921805D0 (en) Drug composition and its use in therapy
GB0910375D0 (en) Drug composition and its use in therapy
GB0905970D0 (en) Depsipeptides and their therapeutic use
GB2460180B (en) Depsipeptides and their therapeutic use
GB0909352D0 (en) Drug composition and its use in therapy
GB0909354D0 (en) Drug composition and its use in therapy
GB0918727D0 (en) Drug composition and its use in therapy
GB0918728D0 (en) Drug composition and its use in therapy
GB0919890D0 (en) Drug composition and its use in therapy
GB0921804D0 (en) Drug composition and its use in therapy
GB0909344D0 (en) Drug composition and its uses in therapy
GB0920267D0 (en) Drug combination and its use in therapy
GB201019971D0 (en) Drug composition and its use in therapy
GB201021425D0 (en) Drug composition and its use in therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)